This article collection will explore the cutting-edge advancements in the integration of biomarkers and nanotechnology for enhancing cancer management. With cancer remaining a leading cause of morbidity and mortality globally, innovative strategies for early detection and targeted therapy are essential for improving patient outcomes.
The collection will cover a wide range of topics, including the development of liquid biopsies and extracellular vesicle (EV)-associated biomarkers for non-invasive cancer detection, as well as the design of nano-based diagnostic platforms that offer high sensitivity and specificity. Additionally, the role of nanotechnology in creating advanced drug delivery systems that enable targeted therapy will be highlighted, showcasing how engineered nanoparticles and EVs can improve therapeutic efficacy while minimizing side effects.
The articles will also address the challenges of translating these technologies from the laboratory to clinical practice, emphasizing the importance of interdisciplinary collaboration among researchers, clinicians, and industry stakeholders. By bringing together the latest research and insights, this collection aims to foster innovation and drive the future of cancer diagnosis and treatment.
Please note manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases that are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of the scope of this Research Topic.
Keywords:
Nanotechnology, early detection, Targeted, Therapy
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
This article collection will explore the cutting-edge advancements in the integration of biomarkers and nanotechnology for enhancing cancer management. With cancer remaining a leading cause of morbidity and mortality globally, innovative strategies for early detection and targeted therapy are essential for improving patient outcomes.
The collection will cover a wide range of topics, including the development of liquid biopsies and extracellular vesicle (EV)-associated biomarkers for non-invasive cancer detection, as well as the design of nano-based diagnostic platforms that offer high sensitivity and specificity. Additionally, the role of nanotechnology in creating advanced drug delivery systems that enable targeted therapy will be highlighted, showcasing how engineered nanoparticles and EVs can improve therapeutic efficacy while minimizing side effects.
The articles will also address the challenges of translating these technologies from the laboratory to clinical practice, emphasizing the importance of interdisciplinary collaboration among researchers, clinicians, and industry stakeholders. By bringing together the latest research and insights, this collection aims to foster innovation and drive the future of cancer diagnosis and treatment.
Please note manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases that are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of the scope of this Research Topic.
Keywords:
Nanotechnology, early detection, Targeted, Therapy
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.